SecBot SecBot

SGRY

Surgery Partners, Inc.
Nasdaq· Services-General Medical & Surgical Hospitals, NEC· Inc. DE· CIK 0001638833 Healthcare & Medical Devices
$23.25 +7.50 (+47.62%)
Oct 26 4:00 PM ET · prev $15.75
Market cap
$2.1B
Mid cap
Consensus
Buy
78% Buy or better · 18 analysts
Median target
$19.00
−18% · range $14.00–24.00
Next earnings
Nov 10
in 15 days
1 year
+1.5%
from $22.90 · Oct 27
30 days
+58.3%
from $14.69
52-week range
$11.49–23.25
at the high
Avg volume 20D
4.65M
Oct 26 spike 58.81M
Short interest
14.35M
≈11.0% of shares · +8.0%
Days to cover
5.3
at average volume
Insider net
−$979.3K
1 buyer · 6 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BULLISH 9 reports · 90 days
Balance 0 bearish · 5 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/9 ·Next Earnings date, Nov 10, 2026
Strongest🔒 Fresh report (last 24h), subscribers only
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $304.7K at an average $14.34. 6 insiders sold $1.3M. Price is 62% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 21 added (0 new), 13 trimmed or exited.

  • AnalystsBULLISH

    14 of 18 rate it Buy or better. Median target $19.00 (−18%).

  • Short sellersSTEADY

    Short interest +8.0% to 14.35M shares. 5.3 days to cover, ≈11.0% of shares.

  • TrendUPTREND

    62% above its 50-day average. New closing high $23.25 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
HSBC HOLDINGS PLCADD2,958,912$48.9M
NOMURA HOLDINGS INCDOUBLED1,525,108$25.6M
VICTORY CAPITAL MANAGEMENT INCADD1,083,812$18.2M
Man Group plcTRIM697,552$11.7M
Hudson Bay Capital Management LPTRIM426,592$7.2M
CITADEL ADVISORS LLCTRIM291,280$4.9M
TD ASSET MANAGEMENT INCDOUBLED158,094$2.7M
TUDOR INVESTMENT CORP ET ALTRIM153,926$2.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 78% rate it Buy or better
Strong Buy5Buy9Hold4Sell0Strong Sell0
12-month targets · 11 analysts

Price is inside the target range. Median implies −18%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 30, 2026RBC Capital
REITERATE
REITERATEOutperform
Sep 18, 2026TD Cowen
REITERATE
REITERATEBuy
Sep 14, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Aug 11, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Aug 11, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 11, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$304.7K
bought · 1 insider
$1.3M
sold · 6 insiders
+62.1%
vs their $14.34 cost
DateInsiderTypeValue
Aug 18, 2026
DeLuca Teresa
Director
BUY$143.5K
Aug 18, 2026
DeLuca Teresa
Director
BUY$161.2K
Jun 18, 2026
HENDRIX BLAIR E
Director
AWARD$500.0K
Jun 5, 2026
Deane John A
Director
AWARD$160.0K
Jun 5, 2026
Forese Laura L
Director
AWARD$160.0K
Jun 5, 2026
ADLERZ CLIFFORD G
Director
AWARD$160.0K
Jun 5, 2026
Dean Lloyd H
Director
AWARD$160.0K
Jun 5, 2026
TURNER BRENT
Director
AWARD$160.0K

Earnings setup

Estimates
Nov 10
reports in 15 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
14,349,417
shares short
+8.0%
vs prior settlement
5.3
days to cover
≈11.0%
of shares outstanding
Trading halts
Oct 26, 2026🔒 Fresh data, subscribers only
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Trading halt
🔒 Fresh data, subscribers only
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Aug 18, 2026 Insider
DeLuca Teresa bought 10,000 shares
Director @ $14.35 ($143.5K)
Aug 18, 2026 Insider
DeLuca Teresa bought 11,250 shares
Director @ $14.33 ($161.2K)
Jul 24, 2026 Press
Surgery Partners announced the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community…
Impact 7/10
Jun 30, 2026 Inst.
HSBC HOLDINGS PLC — ADD
2,958,912 shares ($48.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
SGRY Q3 2026 Earnings Before Market Open — 2026-11-10
Recent
Oct 26, 2026
Trading halt
🔒 Fresh data, subscribers only
Oct 26, 2026
Trading halt
🔒 Fresh data, subscribers only
Sep 17, 2026
Earnings
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading…
Aug 10, 2026
Earnings
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Reaffirms Full Year 2026 Guidance Reaffirms Full Year 2026 Guidance
Aug 10, 2026
Earnings date
SGRY Q2 2026 Earnings Before Market Open — 2026-08-10

SecBot reports

15 filings · 2 press releases · 6 bullish · 1 bearish · 1 mixed · 7 neutral
All SGRY filing & press-release reports (17)